RC The Unforgiven, a series of Ravelin Capital, LP, has successfully completed a private offering, raising a total of $9,999,978. This significant capital influx is noteworthy as it highlights the ongoing interest in venture capital funding amidst a competitive landscape.
The company, incorporated in Delaware and based in Lynnwood, Washington, operates as a limited partnership. According to its recent SEC filing dated October 30, 2026, the offering was fully subscribed, indicating robust demand from investors.
Background
RC The Unforgiven is categorized under pooled investment funds, specifically as a venture capital fund. The company has no publicly listed ticker symbols and operates outside the traditional investment company regulations. Its latest filing, accession number 0002161401-26-000002, reflects its commitment to raising capital for investment purposes.
What the Filing Says
The SEC filing outlines that the offering was completed under Rule 506(b), which provides a safe harbor for private offerings. The total amount raised was $9,999,978, with no remaining funds left to be sold. The filing also notes that the minimum investment accepted was $770,000, and the total number of investors already involved stands at three.
Impact
This successful offering may affect various stakeholders, including the investors who participated, the fund's management team, and the broader venture capital industry. The capital raised will help RC The Unforgiven manage administrative expenses, which is crucial for the operational efficiency of the fund.
What's Next
The filing does not say what happens next. However, the company has indicated its intent to utilize a portion of the proceeds for administrative expenses related to fund management.
Read Next
Workers United Files to Sell $8.4 Million in Amalgamated Stock
Carvana Co. files to sell 10 million shares of stock
Platford Giles Richard to Sell 55,617 Takeda Shares
Takeda's Teresa Bitetti to Sell 46,609 Shares Amid Tax Obligations
Kiniksa Pharmaceuticals reports significant stock sale by officer
Moat Ross to Sell Over 103,000 Shares of Kiniksa Pharmaceuticals










